pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Marketed
linvoseltamab
Lynozyfic (linvoseltamab)
Refractory Multiple Myeloma
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
pre_registration
lirafugratinib hydrochloride
Bile Duct Cancer (Cholangiocarcinoma)
Elevar Therapeutics Inc
0 catalysts
Phase 1
liraltagene autoleucel
Epithelial Ovarian Cancer
$ANIXAnixa Biosciences Inc
0 catalysts
← prev
page 50 of 62
next →
131
Pain89
Neurology1
Phase 3
lisaftoclax
lisaftoclax [INN]
Myelodysplastic Syndrome (Preleukemia)
$AAPGASCENTAGE PHARMA GROUP INTERNATIONAL
0 catalysts
Phase 2
lisocabtagene maraleucel
Breyanzi (lisocabtagene maraleucel)
Chronic Lymphocytic Leukemia (CLL)
B-lymphocyte antigen CD19
Bristol-Myers Squibb Co
0 catalysts
Phase 2
lixadesiran + pixofisiran
lixadesiran [INN] + pixofisiran [INN]
Basal Cell Carcinoma (Basal Cell Epithelioma)
Sirnaomics Ltd
0 catalysts
Phase 1
lixumistat
lixumistat [INN]
Pancreatic Ductal Adenocarcinoma
Immunomet Therapeutics Inc
0 catalysts
Phase 1
lomonitinib
lomonitinib [INN]
Refractory Acute Myeloid Leukemia
Lomond Therapeutics Holdings Inc
0 catalysts
Phase 1
lonitoclax
lonitoclax [INN]
Marginal Zone B-Cell Lymphoma
Lomond Therapeutics Holdings Inc
0 catalysts
Phase 2
lorigerlimab
Colorectal Cancer
$MGNXMACROGENICS INC
0 catalysts
Phase 2
lucicebtide
Esophageal Cancer
Sapience Therapeutics Inc
0 catalysts
Phase 2
ludotadipep
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
FutureChem Co Ltd
0 catalysts
Phase 2
lunbotinib
lunbotinib [INN]
Non-Small Cell Lung Cancer
Ellipses Pharma Ltd
0 catalysts
Phase 3
lutadenovec autogene + sapecmeran autogene
Metastatic Colorectal Cancer
Nexoplex Bio LLC
0 catalysts
Phase 3
lutetium (177Lu) rosopatamab tetraxetan
lutetium (177Lu) rosopatamab tetraxetan [INN]
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$TLXTelix Pharmaceuticals Ltd
0 catalysts
Phase 3
lutetium (177Lu) zadavotide guraxetan
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Curium Midco Sarl
0 catalysts
Marketed
lutetium Lu 177 dotatate
Lutathera (lutetium Lu 177 dotatate)
Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
Somatostatin receptor
Advanced Accelerator Applications SA
0 catalysts
pre_registration
lutetium Lu 177 edotreotide
Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
ITM Isotope Technologies Munich SE
0 catalysts
Phase 2
luvixasertib
luvixasertib [INN]
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Treadwell Therapeutics Inc
0 catalysts
Phase 1
mRNA-4106
Cervical Cancer
$MRNAModerna, Inc.
0 catalysts
Phase 2
mRNA-4359
Solid Tumor
$MRNAModerna, Inc.
0 catalysts
Preclinical
magnesium lysinate bis eicosapentaenoate
Pancreatic Cancer
Thetis Pharmaceuticals LLC
0 catalysts
Phase 2
margetuximab
Margenza (margetuximab-cmkb)
Gastric Cancer
Receptor tyrosine-protein kinase erbB-2
TerSera Therapeutics LLC
0 catalysts
Phase 3
masitinib
masitinib [INN]
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
AB Science SA
0 catalysts
Phase 2
maveropepimut-s
Fallopian Tube Cancer
$BVAXFBioVaxys Technology Corp.
0 catalysts
Phase 2
mavrostobart
Solid Tumor
Phanes Therapeutics Inc
0 catalysts
Phase 2
mecbotamab vedotin
Non-Small Cell Lung Cancer
Tyrosine-protein kinase receptor UFOTubulin
$BCABBioAtla, Inc.
0 catalysts
Marketed
mechlorethamine hydrochloride
Valchlor (mechlorethamine hydrochloride)
Mycosis Fungoides
Helsinn Therapeutics (US) Inc
0 catalysts
Marketed
megestrol acetate
Megestrol Acetate (megestrol acetate)
Anorexia Nervosa
TWi Pharmaceuticals USA Inc
0 catalysts
Marketed
melphalan
Evomela (melphalan)
Retinoblastoma
Zhaoke Ophthalmology Ltd
0 catalysts